XERS   $2.93  -1.01% Market Closed After Close 2.92 -0.34%

Xeris Biopharma Holdings Inc
Total Cash 77.57M
totalCashPerShare 0.521
EBITDA -25.00M
Total Debt 269.80M
quickRatio 1.59
currentRatio 2.257
Total Revenue 181.41M
debtToEquity
Revenue/Share 1.284
ROA -0.07037
ROE
grossProfits
freeCashflow -38.89M
operatingCashflow -37.79M
earningsGrowth
revenueGrowth 0.265
grossMargins 0.83721
ebitdaMargins -0.1378
operatingMargins -0.17033
profitMargins -0.32833
enterpriseValue 621.35M
forwardPE -11.84
floatShares 141.88M
sharesOutstanding 149.00M
sharesShort 10.71M
sharesShortPriorMonth 11.22M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.42%
Short Ratio help_outline 6.82%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue -0.129
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -59.56M
trailingEps -0.42%
forwardEps -0.25%
enterpriseToEbitda -24.86
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.09 3Q 2024
institutionsCount 175
lastUpdated Sept. 16, 2024, 5:45 p.m.